Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 169

1.

Routine Disinfection of Mobile Communication Devices in the Postanesthesia Care Unit.

Wagoner M, Snyder S, McCarty M, Reed L, Flook S, Holsinger J, Leaver CA.

J Perianesth Nurs. 2019 Jun 26. pii: S1089-9472(19)30080-2. doi: 10.1016/j.jopan.2019.03.011. [Epub ahead of print]

PMID:
31255438
2.

A Reduction in B, T, and Natural Killer Cells Expressing CD38 by TAK-079 Inhibits the Induction and Progression of Collagen-Induced Arthritis in Cynomolgus Monkeys.

Korver W, Carsillo M, Yuan J, Idamakanti N, Wagoner M, Shi P, Xia CQ, Smithson G, McLean L, Zalevsky J, Fedyk ER.

J Pharmacol Exp Ther. 2019 Aug;370(2):182-196. doi: 10.1124/jpet.119.256602. Epub 2019 May 13.

PMID:
31085699
3.

Human 3D Gastrointestinal Microtissue Barrier Function As a Predictor of Drug-Induced Diarrhea.

Peters MF, Landry T, Pin C, Maratea K, Dick C, Wagoner MP, Choy AL, Barthlow H, Snow D, Stevens Z, Armento A, Scott CW, Ayehunie S.

Toxicol Sci. 2019 Mar 1;168(1):3-17. doi: 10.1093/toxsci/kfy268.

4.

Feeder-free differentiation of cells exhibiting characteristics of corneal endothelium from human induced pluripotent stem cells.

Wagoner MD, Bohrer LR, Aldrich BT, Greiner MA, Mullins RF, Worthington KS, Tucker BA, Wiley LA.

Biol Open. 2018 May 8;7(5). pii: bio032102. doi: 10.1242/bio.032102.

5.

Glaucoma-associated corneal endothelial cell damage: A review.

Janson BJ, Alward WL, Kwon YH, Bettis DI, Fingert JH, Provencher LM, Goins KM, Wagoner MD, Greiner MA.

Surv Ophthalmol. 2018 Jul - Aug;63(4):500-506. doi: 10.1016/j.survophthal.2017.11.002. Epub 2017 Nov 14. Review.

PMID:
29146208
6.

Evaluation of Temporal Changes in Urine-based Metabolomic and Kidney Injury Markers to Detect Compound Induced Acute Kidney Tubular Toxicity in Beagle Dogs.

Wagoner MP, Yang Y, McDuffie JE, Klapczynski M, Buck W, Cheatham L, Eisinger D, Sace F, Lynch KM, Sonee M, Ma JY, Chen Y, Marshall K, Damour M, Stephen L, Dragan YP, Fikes J, Snook S, Kinter LB.

Curr Top Med Chem. 2017;17(24):2767-2780. doi: 10.2174/1568026617666170713172331.

PMID:
28714420
7.

Towards better models and mechanistic biomarkers for drug-induced gastrointestinal injury.

Carr DF, Ayehunie S, Davies A, Duckworth CA, French S, Hall N, Hussain S, Mellor HR, Norris A, Park BK, Penrose A, Pritchard DM, Probert CS, Ramaiah S, Sadler C, Schmitt M, Shaw A, Sidaway JE, Vries RG, Wagoner M, Pirmohamed M.

Pharmacol Ther. 2017 Apr;172:181-194. doi: 10.1016/j.pharmthera.2017.01.002. Epub 2017 Jan 27. Review.

PMID:
28132905
8.

Incidence and Outcomes of Positive Donor Corneoscleral Rim Fungal Cultures after Keratoplasty.

Vislisel JM, Goins KM, Wagoner MD, Schmidt GA, Aldrich BT, Skeie JM, Reed CR, Zimmerman MB, Greiner MA.

Ophthalmology. 2017 Jan;124(1):36-42. doi: 10.1016/j.ophtha.2016.09.017. Epub 2016 Nov 3.

PMID:
27817919
9.

A high-throughput in vitro ring assay for vasoactivity using magnetic 3D bioprinting.

Tseng H, Gage JA, Haisler WL, Neeley SK, Shen T, Hebel C, Barthlow HG, Wagoner M, Souza GR.

Sci Rep. 2016 Aug 1;6:30640. doi: 10.1038/srep30640.

10.

Boston Type 1 Keratoprosthesis: Visual Outcomes, Device Retention, and Complications.

Goins KM, Kitzmann AS, Greiner MA, Kwon YH, Alward WL, Ledolter J, Wagoner MD.

Cornea. 2016 Sep;35(9):1165-74. doi: 10.1097/ICO.0000000000000886.

PMID:
27191675
11.

Incidence of Cystoid Macular Edema After Descemet Membrane Endothelial Keratoplasty as a Staged and Solitary Procedure.

Flanary WE, Vislisel JM, Wagoner MD, Raecker ME, Aldrich BT, Zimmerman MB, Goins KM, Greiner MA.

Cornea. 2016 Aug;35(8):1040-4. doi: 10.1097/ICO.0000000000000870.

PMID:
27158809
12.

Effect of Group Setting on Gross Motor Performance in Children 3-5 Years Old with Motor Delays.

Fay D, Wilkinson T, Wagoner M, Brooks D, Quinn L, Turnell A.

Phys Occup Ther Pediatr. 2017 Feb;37(1):74-86. doi: 10.3109/01942638.2015.1129387. Epub 2016 Feb 25.

PMID:
26913487
13.

Microbial Keratitis and Endophthalmitis After the Boston Type 1 Keratoprosthesis.

Wagoner MD, Welder JD, Goins KM, Greiner MA.

Cornea. 2016 Apr;35(4):486-93. doi: 10.1097/ICO.0000000000000738.

PMID:
26764885
14.

A Simple and Reliable Technique to Orient Donor Corneal Tissue Using the Radial Width of the Surgical Limbus.

Aldrich BT, Stockman AM, Freiburger MJ, Shinkunas TJ, Burckart KA, Schmidt GA, Reed CR, Zimmerman MB, Goins KM, Wagoner MD, Greiner MA.

Cornea. 2015 Dec;34(12):1632-6. doi: 10.1097/ICO.0000000000000652.

PMID:
26488631
15.

Boston Type 1 Keratoprosthesis for Iridocorneal Endothelial Syndromes.

Phillips DL, Goins KM, Greiner MA, Alward WL, Kwon YH, Wagoner MD.

Cornea. 2015 Nov;34(11):1383-6. doi: 10.1097/ICO.0000000000000616.

PMID:
26398156
16.

Boston type 1 keratoprosthesis for primary congenital glaucoma.

Haugsdal JM, Goins KM, Greiner MA, Kwon YH, Alward WL, Wagoner MD.

Br J Ophthalmol. 2016 Mar;100(3):328-31. doi: 10.1136/bjophthalmol-2015-307190. Epub 2015 Jul 23.

PMID:
26206789
17.

Regional assessment of energy-producing metabolic activity in the endothelium of donor corneas.

Greiner MA, Burckart KA, Wagoner MD, Schmidt GA, Reed CR, Liaboe CA, Flamme-Wiese MJ, Zimmerman MB, Mullins RF, Kardon RH, Goins KM, Aldrich BT.

Invest Ophthalmol Vis Sci. 2015 May;56(5):2803-10. doi: 10.1167/iovs.15-16442.

PMID:
26024071
18.

Descriptive Quantitative Analysis of Rearfoot Alignment Radiographic Parameters.

Meyr AJ, Wagoner MR.

J Foot Ankle Surg. 2015 Sep-Oct;54(5):860-71. doi: 10.1053/j.jfas.2015.02.011. Epub 2015 May 20.

PMID:
26002682
19.

Boston type 1 keratoprosthesis for failed keratoplasty.

Hager JL, Phillips DL, Goins KM, Kitzmann AS, Greiner MA, Cohen AW, Welder JD, Wagoner MD.

Int Ophthalmol. 2016 Feb;36(1):73-78. doi: 10.1007/s10792-015-0078-2. Epub 2015 May 16.

PMID:
25975459
20.

Pictorial Review and Basic Principles of Foot and Ankle Hardware Extraction.

Wagoner MR, Creech CL, Nolan CK, Meyr AJ.

Foot Ankle Spec. 2015 Aug;8(4):305-13. doi: 10.1177/1938640015585964. Epub 2015 May 8. Review.

PMID:
25956873
21.

Graft survival of diabetic versus nondiabetic donor tissue after initial keratoplasty.

Vislisel JM, Liaboe CA, Wagoner MD, Goins KM, Sutphin JE, Schmidt GA, Zimmerman MB, Greiner MA.

Cornea. 2015 Apr;34(4):370-4. doi: 10.1097/ICO.0000000000000378.

PMID:
25642643
22.

Treatment of acanthamoeba keratitis with intravenous pentamidine before therapeutic keratoplasty.

Sacher BA, Wagoner MD, Goins KM, Sutphin JE, Greiner MA, Kitzmann AS.

Cornea. 2015 Jan;34(1):49-53. doi: 10.1097/ICO.0000000000000263.

PMID:
25255139
23.

Diabetes mellitus increases risk of unsuccessful graft preparation in Descemet membrane endothelial keratoplasty: a multicenter study.

Greiner MA, Rixen JJ, Wagoner MD, Schmidt GA, Stoeger CG, Straiko MD, Zimmerman MB, Kitzmann AS, Goins KM.

Cornea. 2014 Nov;33(11):1129-33. doi: 10.1097/ICO.0000000000000262.

PMID:
25222000
24.

Boston type 1 keratoprosthesis for chemical and thermal injury.

Phillips DL, Hager JL, Goins KM, Kitzmann AS, Greiner MA, Cohen AW, Welder JD, Wagoner MD.

Cornea. 2014 Sep;33(9):905-9. doi: 10.1097/ICO.0000000000000204.

PMID:
25055151
25.

Boston keratoprosthesis type 1 for herpes simplex and herpes zoster keratopathy.

Brown CR, Wagoner MD, Welder JD, Cohen AW, Goins KM, Greiner MA, Kitzmann AS.

Cornea. 2014 Aug;33(8):801-5. doi: 10.1097/ICO.0000000000000164.

PMID:
24932767
26.

Graft survival versus glaucoma treatment after penetrating or Descemet stripping automated endothelial keratoplasty.

Ward MS, Goins KM, Greiner MA, Kitzmann AS, Sutphin JE, Alward WL, Greenlee EC, Kwon YH, Zimmerman MB, Wagoner MD.

Cornea. 2014 Aug;33(8):785-9. doi: 10.1097/ICO.0000000000000170.

PMID:
24915017
27.

Can foot and ankle surgeons accurately estimate patient body mass index?

Wagoner MR, Van JC, Nolan CK, Creech CL, Cornell RS, Meyr AJ.

J Foot Ankle Surg. 2014 Jan-Feb;53(1):36-40. doi: 10.1053/j.jfas.2013.09.017. Epub 2013 Nov 13.

PMID:
24239428
28.

Early prediction of polymyxin-induced nephrotoxicity with next-generation urinary kidney injury biomarkers.

Keirstead ND, Wagoner MP, Bentley P, Blais M, Brown C, Cheatham L, Ciaccio P, Dragan Y, Ferguson D, Fikes J, Galvin M, Gupta A, Hale M, Johnson N, Luo W, McGrath F, Pietras M, Price S, Sathe AG, Sasaki JC, Snow D, Walsky RL, Kern G.

Toxicol Sci. 2014 Feb;137(2):278-91. doi: 10.1093/toxsci/kft247. Epub 2013 Nov 4.

PMID:
24189134
29.

Outcomes of treatment of fungal keratitis at the University of Iowa Hospitals and Clinics: a 10-year retrospective analysis.

Rogers GM, Goins KM, Sutphin JE, Kitzmann AS, Wagoner MD.

Cornea. 2013 Aug;32(8):1131-6. doi: 10.1097/ICO.0b013e3182883e9d.

PMID:
23538629
30.

Treatment of aniridia with Boston type I keratoprosthesis.

Rixen JJ, Cohen AW, Kitzmann AS, Wagoner MD, Goins KM.

Cornea. 2013 Jul;32(7):947-50. doi: 10.1097/ICO.0b013e318281724a.

PMID:
23449480
31.

A REST derived gene signature stratifies glioblastomas into chemotherapy resistant and responsive disease.

Wagoner MP, Roopra A.

BMC Genomics. 2012 Dec 7;13:686. doi: 10.1186/1471-2164-13-686.

32.

Confirmation of the association between the TCF4 risk allele and Fuchs endothelial corneal dystrophy in patients from the Midwestern United States.

Stamler JF, Roos BR, Wagoner MD, Goins KM, Kitzmann AS, Riley JB, Stone EM, Fingert JH.

Ophthalmic Genet. 2013 Mar-Jun;34(1-2):32-4. doi: 10.3109/13816810.2012.726396. Epub 2012 Sep 24.

PMID:
22998502
33.

Reply. Phakic descemet stripping automated endothelial keratoplasty: prevalence and prognostic impact of postoperative cataracts.

Tsui JY, Goins KM, Sutphin JE, Wagoner MD.

Cornea. 2012 Dec;31(12):1508. doi: 10.1097/ICO.0b013e31825904c0. No abstract available.

PMID:
22955122
34.

Induction of the RNA regulator LIN28A is required for the growth and pathogenesis of RESTless breast tumors.

Gunsalus KT, Wagoner MP, Meyer K, Potter WB, Schoenike B, Kim S, Alexander CM, Friedl A, Roopra A.

Cancer Res. 2012 Jul 1;72(13):3207-16. doi: 10.1158/0008-5472.CAN-11-1639. Epub 2012 Apr 24.

35.

Photorefractive keratectomy modification of postkeratoplasty anisometropic refractive errors.

Ward MS, Wandling GR, Goins KM, Sutphin JE, Kitzmann AS, Wagoner MD.

Cornea. 2013 Mar;32(3):273-9. doi: 10.1097/ICO.0b013e31824a22a4.

PMID:
22475643
36.

Impact of eye bank lamellar tissue cutting for endothelial keratoplasty on bacterial and fungal corneoscleral donor rim cultures after corneal transplantation.

Rauen MP, Goins KM, Sutphin JE, Kitzmann AS, Schmidt GA, Wagoner MD.

Cornea. 2012 Apr;31(4):376-9. doi: 10.1097/ICO.0b013e31823cbee3.

PMID:
22410614
37.

The "silent brain syndrome" creating a severe form of the "giant fornix syndrome".

Chen JJ, Cohen AW, Wagoner MD, Allen RC.

Cornea. 2012 Sep;31(9):1065-7. doi: 10.1097/ICO.0b013e31823f8e65.

PMID:
22357388
38.

Comparison of outcomes of penetrating keratoplasty versus Descemet's stripping automated endothelial keratoplasty for penetrating keratoplasty graft failure due to corneal edema.

Kitzmann AS, Wandling GR, Sutphin JE, Goins KM, Wagoner MD.

Int Ophthalmol. 2012 Feb;32(1):15-23. doi: 10.1007/s10792-012-9518-4. Epub 2012 Jan 22.

PMID:
22271071
39.

Glaucoma therapy escalation in eyes with pseudophakic corneal edema after penetrating keratoplasty and Descemet's stripping automated endothelial keratoplasty.

Wandling GR Jr, Rauen MP, Goins KM, Kitzmann AS, Sutphin JE, Kwon YH, Alward WL, Wagoner MD.

Int Ophthalmol. 2012 Feb;32(1):9-14. doi: 10.1007/s10792-011-9512-2. Epub 2012 Jan 13.

PMID:
22246622
40.

Phakic descemet stripping automated endothelial keratoplasty: prevalence and prognostic impact of postoperative cataracts.

Tsui JY, Goins KM, Sutphin JE, Wagoner MD.

Cornea. 2011 Mar;30(3):291-5. doi: 10.1097/ICO.0b013e3181eeb5ba.

PMID:
21099414
41.

Retrospective review of graft dislocation rate associated with descemet stripping automated endothelial keratoplasty after primary failed penetrating keratoplasty.

Clements JL, Bouchard CS, Lee WB, Dunn SP, Mannis MJ, Reidy JJ, John T, Hannush SB, Goins KM, Wagoner MD, Adi MA, Rubenstein JB, Udell IJ, Babiuch AS.

Cornea. 2011 Apr;30(4):414-8. doi: 10.1097/ICO.0b013e3181f7f163.

PMID:
21099405
42.

Comparison of bifold forceps and cartridge injector suture pull-through insertion techniques for Descemet stripping automated endothelial keratoplasty.

Wendel LJ, Goins KM, Sutphin JE, Wagoner MD.

Cornea. 2011 Mar;30(3):273-6. doi: 10.1097/ICO.0b013e3181eadb84.

PMID:
21045670
43.

Penetrating keratoplasty versus deep anterior lamellar keratoplasty for the treatment of keratoconus.

Cohen AW, Goins KM, Sutphin JE, Wandling GR, Wagoner MD.

Int Ophthalmol. 2010 Dec;30(6):675-81. doi: 10.1007/s10792-010-9393-9. Epub 2010 Sep 23.

PMID:
20862520
44.

Treatment of ocular surface squamous cell intraepithelial neoplasia with and without mitomycin C.

Birkholz ES, Goins KM, Sutphin JE, Kitzmann AS, Wagoner MD.

Cornea. 2011 Jan;30(1):37-41. doi: 10.1097/ICO.0b013e3181dee560.

PMID:
20861726
45.

The transcription factor REST is lost in aggressive breast cancer.

Wagoner MP, Gunsalus KT, Schoenike B, Richardson AL, Friedl A, Roopra A.

PLoS Genet. 2010 Jun 10;6(6):e1000979. doi: 10.1371/journal.pgen.1000979.

46.

Initial resident refractive surgical experience: outcomes of PRK and LASIK for myopia.

Wagoner MD, Wickard JC, Wandling GR Jr, Milder LC, Rauen MP, Kitzmann AS, Sutphin JE, Goins KM.

J Refract Surg. 2011 Mar;27(3):181-8. doi: 10.3928/1081597X-20100521-02. Epub 2010 Jun 1.

PMID:
20540469
47.

Escalation of glaucoma therapy after deep lamellar endothelial keratoplasty.

Wandling GR Jr, Parikh M, Robinson C, Pramanik SN, Goins KM, Sutphin JE, Alward WL, Greenlee EC, Kwon YH, Wagoner MD.

Cornea. 2010 Sep;29(9):991-5. doi: 10.1097/ICO.0b013e3181cc7b02.

PMID:
20520533
48.

Metabolic regulation of neuronal plasticity by the energy sensor AMPK.

Potter WB, O'Riordan KJ, Barnett D, Osting SM, Wagoner M, Burger C, Roopra A.

PLoS One. 2010 Feb 1;5(2):e8996. doi: 10.1371/journal.pone.0008996.

49.

Demographics, etiology, and behavior of conjunctival squamous cell carcinoma in the 21st century.

Karcioglu ZA, Wagoner MD.

Ophthalmology. 2009 Nov;116(11):2045-6. doi: 10.1016/j.ophtha.2009.09.031. No abstract available.

PMID:
19883851
50.

Deep anterior lamellar keratoplasty: when should it replace penetrating keratoplasty?

Sutphin JE, Goins KM, Wagoner MD.

Am J Ophthalmol. 2009 Nov;148(5):629-31. doi: 10.1016/j.ajo.2009.07.011. No abstract available.

PMID:
19878753

Supplemental Content

Loading ...
Support Center